Compare Abbott India with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TTK HEALTHCARE - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TTK HEALTHCARE ABBOTT INDIA/
TTK HEALTHCARE
 
P/E (TTM) x 57.7 22.2 259.8% View Chart
P/BV x 17.1 1.5 1,148.5% View Chart
Dividend Yield % 0.4 1.0 38.8%  

Financials

 ABBOTT INDIA   TTK HEALTHCARE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
TTK HEALTHCARE
Mar-19
ABBOTT INDIA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs8,8341,215 727.1%   
Low Rs5,458610 894.5%   
Sales per share (Unadj.) Rs1,731.1444.4 389.6%  
Earnings per share (Unadj.) Rs211.917.2 1,228.7%  
Cash flow per share (Unadj.) Rs219.927.6 795.8%  
Dividends per share (Unadj.) Rs65.005.00 1,300.0%  
Dividend yield (eoy) %0.90.5 166.0%  
Book value per share (Unadj.) Rs945.2177.9 531.2%  
Shares outstanding (eoy) m21.2514.13 150.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.1 201.0%   
Avg P/E ratio x33.752.9 63.7%  
P/CF ratio (eoy) x32.533.0 98.4%  
Price / Book Value ratio x7.65.1 147.4%  
Dividend payout %30.729.0 105.8%   
Avg Mkt Cap Rs m151,84812,894 1,177.6%   
No. of employees `0003.52.3 150.7%   
Total wages/salary Rs m4,3561,307 333.3%   
Avg. sales/employee Rs Th10,555.52,715.7 388.7%   
Avg. wages/employee Rs Th1,249.9565.3 221.1%   
Avg. net profit/employee Rs Th1,292.2105.4 1,225.9%   
INCOME DATA
Net Sales Rs m36,7866,279 585.9%  
Other income Rs m1,13378 1,461.8%   
Total revenues Rs m37,9196,356 596.6%   
Gross profit Rs m6,047496 1,220.2%  
Depreciation Rs m169147 115.3%   
Interest Rs m2334 66.6%   
Profit before tax Rs m6,989393 1,780.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485149 1,669.0%   
Profit after tax Rs m4,503244 1,847.9%  
Gross profit margin %16.47.9 208.3%  
Effective tax rate %35.637.9 93.8%   
Net profit margin %12.23.9 315.4%  
BALANCE SHEET DATA
Current assets Rs m27,6102,717 1,016.1%   
Current liabilities Rs m8,5691,571 545.5%   
Net working cap to sales %51.818.3 283.5%  
Current ratio x3.21.7 186.3%  
Inventory Days Days6032 187.3%  
Debtors Days Days2747 58.7%  
Net fixed assets Rs m1,057991 106.6%   
Share capital Rs m213141 150.4%   
"Free" reserves Rs m19,8732,373 837.5%   
Net worth Rs m20,0862,514 798.9%   
Long term debt Rs m03 0.0%   
Total assets Rs m29,4094,158 707.3%  
Interest coverage x311.612.6 2,470.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.31.5 82.8%   
Return on assets %15.46.7 230.6%  
Return on equity %22.49.7 231.3%  
Return on capital %34.916.9 206.1%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m369225 163.8%   
Fx outflow Rs m4,91871 6,916.6%   
Net fx Rs m-4,549154 -2,952.5%   
CASH FLOW
From Operations Rs m4,991173 2,883.5%  
From Investments Rs m-2,57097 -2,663.2%  
From Financial Activity Rs m-1,428-307 464.7%  
Net Cashflow Rs m993-38 -2,634.7%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 5.2 1.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 25.8 66.3%  
Shareholders   18,270 12,723 143.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Lower; Tata Steel & Maruti Suzuki Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note, tracking a selloff in global equities amid rising concerns over Chinese coronavirus epidemic.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 24, 2020 01:43 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS